Skip to main content
Log in

Recombinant human growth hormone treatment at low doses does not significantly change thyroid function in growth hormone deficient adults

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Pituitary-thyroid changes have been reported during recombinant human growth hormone (rhGH) therapy at the dose commonly used in pre-puberty. We have previously demonstrated that low doses of rhGH were able to normalize body composition and both cardiac structure and function in growth hormone deficient adults (GHDA), without causing any of the side effects described when the GHDA were treated with doses commonly employed in the GHD children. The aim of this study was to evaluate the behaviour of pituitary-thyroid parameters in GHDA undergoing such a low dose of rhGH treatment. We studied 9 (2 females and 7 males, 25–34 yr) GHDA, 7 congenital and 2 acquired GH deficiency, before, during and after a 12-month rhGH treatment at dose of 10 μg/kg/day (=70 μg/kg/week) divided in 3 injections, administered sc at 20:00 h on Monday, Wednesday and Friday, respectively. Thyroid deficiency and other hormonal deficiencies, when present, had been adequately corrected with replacement therapy. Serum IGF1, T3, T4, free-T3, free-T4, TSH, reverse-T3, T3/T4 and FT3/FT4 ratios were studied basally, every 3 months during the 12-month rhGH treatment and every 3 months for a period of 12 months off therapy. Analysis of variance (ANOVA) was performed as statistical method. All parameters (except IGF1) did not show any variation during and after rhGH treatment at low doses. The alterations of T3 and T4 metabolism, in the sense of a T3 increase and a T4 reduction, caused sometimes by rhGH treatment, could be due to the higher doses used and therefore should be considered another side effect, like artrhalgia, fluid retention, carpal tunnel syndrome, etc.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Oliner L., Ballantine J.J. Effect of human growth hormone on thyroidal secretion, radiothyroxine turnover and transport in man. J. Clin. Endocrinol. Metab. 28: 603, 1968.

    Article  CAS  PubMed  Google Scholar 

  2. Sack J., DeLamater P. Hypothyroidism after growth hormone therapy. Pediatrics 52: 625, 1973.

    Google Scholar 

  3. Porter B.A., Refetoff S., Rosenfield R.L., De Groot L.J., Fang V.S., Stark V. Abnormal thyroxine metabolism in hyposomatotrophic dwarfism and inhibition of responsiveness to TRH during GH therapy. Pediatrics 51: 668, 1973.

    CAS  PubMed  Google Scholar 

  4. Lippe B.M., Van Herle A.J., La Franchi S.H., Uller R.P., Lavin N., Kaplan S.A. Reversible hypothyroidism in growth hormone-deficient children treated with human growth hormone. J. Clin. Endocrinol. Metab. 40: 612, 1975.

    Article  CAS  PubMed  Google Scholar 

  5. Sato T., Suzuki Y., Taketani T., Ishiguro K., Masuyama T., Takata I., Sano M., Kawashima H., Koizumi S., Nakajima H. Enhanced peripheral conversion of thyroxine to triiodothyronine during hGH therapy -in GH deficient children. J. Clin. Endocrinol. Metab. 45: 324, 1976.

    Article  Google Scholar 

  6. Rosenbloom A.L., Riley W.J., Silverstein J.H., Garnica A.D., Netzloff M.L., Weber F.T. Low dose single weekly -injections of growth hormone: response during first year of therapy of hypopituitarism. Pediatrics 66: 272, 1980.

    CAS  PubMed  Google Scholar 

  7. Demura R., Yamaguchi H., Wakabayashi I., Demura H., Shizume K. The effect of hGH on hypothalamic-pituitary-thyroid function in patients with pituitary dwarfism. Acta Endocrinol. (Copenh.) 93: 13, 1980.

    CAS  Google Scholar 

  8. Rezvani I., DiGeorge A.M., Dowshen S.A., Bourdony C.J. Action of human growth hormone (hGH) on extrathyroidal conversion of thyroxine (T4) to triiodothyronine (T3) in children with hypopituitarism. Pediatr. Res. 15: 6, 1981.

    Article  CAS  PubMed  Google Scholar 

  9. Stahnke N., Koehn H. Replacement therapy in hypothalamus-pituitary insufficiency: management in the adolescent. Horm. Res. 33: 38, 1990.

    Article  PubMed  Google Scholar 

  10. Pirazzoli P., Cacciari E., Mandini M., Sganga T., Capelli M., Cicognani A., Gualandi S. Growth and thyroid function in children treated with growth hormone. J. Pediatr. 121: 210, 1991.

    Article  Google Scholar 

  11. Sacco V., Maioli A., Citro G., Galasso R., Vinci M.L., Zampino A. Effetti del trattamento con GH-biosintetico sulla funzione tiroidea in soggetti con deficit isolato di GH. Minerva Endocrinol. 17: 13, 1992.

    CAS  PubMed  Google Scholar 

  12. Grunfeld C., Sherman B.M., Cavalieri R.R. The acute effects of human growth hormone administration on thyroid function in normal men. J. Clin. Endocrinol. Metab. 67: 1111, 1988.

    Article  CAS  PubMed  Google Scholar 

  13. Ho K.J., Weissemberg A.J., Stuart M.C., Day R.O., Lazarus L. The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects. Clin. Endocrinol. (Oxf.) 30: 335, 1989.

    Article  CAS  Google Scholar 

  14. Brixen K., Nielsen H.K., Bouillon R., Flyvbjerg A., Mosekilde L. Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin and glucagon. Acta Endocrinol. (Copenh.) 127: 331, 1992.

    CAS  Google Scholar 

  15. Jorgensen J.O.L., Moller J., Skakkebaek N.E., Weeke J., Christiansen J.S. Thyroid function during growth hormone therapy. Horm. Res. 38: 63, 1992.

    Article  PubMed  Google Scholar 

  16. Moeller J., Jorgensen J.O.L., Moller N., Christiansen J.S., Weeke J. Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metabolism 41: 728, 1992.

    Article  CAS  Google Scholar 

  17. Deyssig R., Frisch H., Blum W.F., Waldhor T. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol. (Copenh.) 127: 331, 1993.

    Google Scholar 

  18. Jorgensen J.O.L., Pedersen S.A., Thuesen L., Jorgensen J., Ingemann-Hansen T., Christiansen J.S. Beneficial effects of growth hormone treatment in CH-deficient adults. Lancet. 1: 1221, 1989.

    Article  CAS  PubMed  Google Scholar 

  19. Salomon F., Cuneo R.C., Hesp R., Sonksen P.H. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321: 1797, 1989.

    Article  CAS  PubMed  Google Scholar 

  20. Binnerts O., Swart G.R., Wilson J.H.P., Hoogerbrugge N., Pols H.A.P., Birkenhager J.C., Lamberts S.W.J. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostatis, as well as on body composition. Clin. Endocrinol. (Oxf.) 37: 79, 1992.

    Article  CAS  Google Scholar 

  21. Bengtsson B-A., Staffan E., Lonn L., Kvist H., Stokland A., Lindstedt G., Bosaeus I., Tolli J., Sjostrom L., Isaksson O.G.P. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J. Clin. Endocrinol. Metab. 76: 309, 1993.

    CAS  PubMed  Google Scholar 

  22. Jorgensen J.O.L., Moller J., Laursen T., Orskov H., Christiansen J.S., Weeke J. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin. Endocrinol. (Oxf.) 41: 609, 1994.

    Article  CAS  Google Scholar 

  23. Stenlof K., Sjostrom L., Lonn L., Bosaeus I., Kvist H., Tolli J., Lindstedt G., Bengtsson B.-A. Effects of recombinant human growth hormone on basal metabolic rate in adults with pituitary deficiency. Metabolism 44: 67, 1995.

    Article  CAS  PubMed  Google Scholar 

  24. Amato G., Carella C., Fazio S., La Montagna G., Cittadini A., Sabatini D., Marciano-Mone C., Sacca L., Bellastella A. Body composition, bone metabolism and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. Metab. 77: 1671, 1993.

    CAS  PubMed  Google Scholar 

  25. Cuneo R.C., Salomon F., McGauley G.A., Sonksen P.H. The growth hormone deficiency syndrome in adults. Clin. Endocrinol. (Oxf.) 37: 387, 1992.

    Article  CAS  Google Scholar 

  26. Jenkins D., Stewart P.M. Advances in medical therapy for pituitary disease: treating patients with growth hormone excess and deficiency. J. Clin. Pharmacol Ther. 18: 155, 1993.

    Article  CAS  Google Scholar 

  27. Klinger B., Ionesco A., Anin S., Laron Z. Effects of insulin-like growth factor I on the thyroid axis in patients with Laron-type dwarfism and healthy subjects. Acta Endocrinol. (Copenh.) 127: 515, 1992.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amato, G., Izzo, G., Salzano, I. et al. Recombinant human growth hormone treatment at low doses does not significantly change thyroid function in growth hormone deficient adults. J Endocrinol Invest 19, 563–566 (1996). https://doi.org/10.1007/BF03349017

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349017

Keywords

Navigation